A randomized, double-blind, placebo-controlled, parallel-group clinical trial was carried out to compare 24-week periods of treatment with 1 g acetyl-l-carnitine twice daily and placebo in the treatment of patients with dementia of the Alzheimer type. A total of 36 patients entered the trial, of whom 20 patients (7 active, 13 placebo) completed the full 24 weeks. Whilst several of the efficacy indices showed little change in either group during the trial, there was an apparent trend for more improvement in the acetyl-l-carnitine group in relation to the Names Learning Test and a computerized Digit Recall Test, both related to aspects of short-term memory.
View Article and Find Full Text PDFEvent-related potentials particularly the P3 component have been noted to be abnormal in illnesses affecting cognitive processes, such as dementia. The relationship between the P3 latency and objective tests of mental function in patients with Alzheimer's disease and vascular dementia has been studied. A significant correlation was demonstrated between P3 latency and automated psychometric tests in patients with Alzheimer's disease.
View Article and Find Full Text PDFMemory impairment is a salient and early feature of developing dementia, but in practice is often not recognised until it has reached an advanced stage. The operation described is of a Memory Clinic opened on an experimental basis at the Geriatric Research Unit, University College London, in 1983, with the aim of identifying the causes of memory impairment in the elderly, with particular reference to the early detection of dementia. It proved possible to identify a group of people with early dementia who had previously been undiagnosed, and also to reveal deficiencies in the utilisation of existing services.
View Article and Find Full Text PDFMean deep body temperature fell by 0.4 +/- 0.1 (SD) degrees C in five sedentary, clothed 63-70 year old men and by 0.
View Article and Find Full Text PDF